Skip to main content
SpringerLink
Log in

Carmustin (z.B. Carmubris®)

  • Chapter
Paravasation von Zytostatika

  • 731 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Primärliteratur

  1. De Vita VT, Carbone PP, Owens AH, et al: Clinical trials with 1,3-bis (2-chloroethyl)-1-nitrosourea, NSC-409962. Cancer Res 25: 1876–1881, 1965.

    PubMed  Google Scholar 

  2. Marsh JC, DeConti RC, Hubbard SP: Treatment of Hodgkin s disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962). Cancer Chemother Rep 55: 599–606, 1971.

    PubMed  CAS  Google Scholar 

  3. Gaze NR: Tissue necrosis caused by commonly used intravenous infusions. Lancet 2: 417–419, 1978.

    Article  PubMed  CAS  Google Scholar 

  4. Jackson IT, Robinson DW: Severe tissue damage following accidental subcutaneous infusion of bicarbonate solution. Scot Med J 21: 200–201, 1976.

    PubMed  CAS  Google Scholar 

  5. Colvin M, Hartner J, Summerfield M: Stability of carmustine in the presence of sodium bicarbonate. Am J Hosp Pharm 37: 677–678, 1980.

    PubMed  CAS  Google Scholar 

  6. Laskar PA, Ayres JW: Degradation of carmustine in aqueous media. J Pharm Sci 66: 1073–1076, 1977.

    PubMed  CAS  Google Scholar 

  7. Loth TS, Eversmann WW: Treatment methods for extravasations of chemotherapeutic agents: a comparative study. J Hand Surg 11A: 388–396, 1986.

    Google Scholar 

Sekundärliteratur

  1. Ignoffo RJ, Friedman MA: Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7: 17–27, 1980.

    PubMed  CAS  Google Scholar 

  2. Stanley A: Managing complications of chemotherapy administration. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 4th edition: 119–193, 2002.

    Google Scholar 

  3. Allwood M: Chemotherapeutic agents: carmustine. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 4th edition: 282–285, 2002.

    Google Scholar 

  4. Dorr RT: Pharmacologic management of vesicant chemotherapy extravasations. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 109–118, 1994.

    Google Scholar 

  5. Dorr RT, Von Hoff DD: Drug monographs: carmustine. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 267–275, 1994.

    Google Scholar 

  6. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Fachinformation Carmubris® (Deutschland), Bristol-Myers Squibb, Februar 2005.

    Google Scholar 

  8. Krämer I: Zytostatika-Paravasate-Set. Krankenhauspharmazie 13: 154–160, 1992.

    Google Scholar 

  9. Schneider SM, Distelhorst CW: Chemotherapy-induced emergencies. Semin Oncol 16: 572–578, 1989.

    PubMed  CAS  Google Scholar 

  10. Cox K, Stuart-Harris R, Abdini G, et al: The management of cytotoxicdrug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 148: 185–189, 1988.

    PubMed  CAS  Google Scholar 

  11. Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.

    Article  PubMed  CAS  Google Scholar 

  12. Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6. Auflage: 1–17, 1999.

    Google Scholar 

  13. Donislawski S, Gain M, Meyer-Jürshof A, et al: Carmustin: Behandlung von Paravasaten. In: Donislawski S, et al (Hrsg) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 2: 21, 1994.

    Google Scholar 

  14. Holmes BC: Administration of cancer chemotherapy agents. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 57–94, 1994.

    Google Scholar 

  15. Gain M, Melzer S, Meyer-Jürshof A, et al: Allgemeiner Teil: Behandlung von Paravasaten. In: Gain M, et al (Hrsg) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 1, 2. Auflage: A42–44, 1997.

    Google Scholar 

  16. Barth J: Paravasate und deren Behandlung. In: Barth J (Hrsg) Zytostatika-Herstellung in der Apotheke. Deutscher Apotheker Verlag, Kap. VI-3: 1–9, 2000.

    Google Scholar 

  17. Krämer I, Stützle M: Zytostatika-Paravasation — Wie ist vorzugehen? Krankenhauspharmazie 23: 261–268, 2002.

    Google Scholar 

  18. Ener RA, Meglathery SB, Styler M: Extravasation of systemic hematooncological therapies. Ann Oncol 15: 858–862, 2004.

    Article  PubMed  CAS  Google Scholar 

  19. Jordan K, Grothe W, Schmoll HJ: Paravasation von Zytostatika: Prävention und Therapie. Dtsch Med Wochenschr 130: 33–37, 2005.

    Article  PubMed  CAS  Google Scholar 

Zusätzlich wurden folgende Publikationen zum Literaturstudium herangezogen

  1. Fenchel K, Karthaus M: Zytostatika-Paravasate — gibt es neue Empfehlungen zum therapeutischen Vorgehen? Wien Med Wochenschr 151: 44–46, 2001.

    PubMed  CAS  Google Scholar 

  2. Koppel RA, Boh EE: Cutaneous reactions to chemotherapeutic agents. Am J Med Sci 321: 327–335, 2001.

    Article  PubMed  CAS  Google Scholar 

  3. Rauh J, Pluntke S, Müller C: Paravenöse Zytostatikainjektion: Prophylaxe und Sofortmaßnahmen im Notfall. MMW Fortschr Med 146: 682–686, 2004.

    Google Scholar 

  4. Schrijvers DL: Extravasation: a dreaded complication of chemotherapy. Ann Oncol 14: iii26–iii30, 2003.

    PubMed  Google Scholar 

Download references

Authors
  1. Patrizia Fürst-Weger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Fürst-Weger, P. (2006). Carmustin (z.B. Carmubris®). In: Paravasation von Zytostatika. Springer, Vienna. https://doi.org/10.1007/3-211-36215-0_19

Download citation

  • DOI: https://doi.org/10.1007/3-211-36215-0_19

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-25225-3

  • Online ISBN: 978-3-211-36215-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation